According to a recent report from WebMD News, a recent study, which asserted both Xarelto and Pradaxa were superior to Warfarin, found that Xarelto poses a higher risk of serious internal bleeding disorders than its competitor, Pradaxa. The drugs at issue are part of a new class of anticoagulants known…
For many years, if someone needed a blood thinner, he or she would take Warfarin (Coumadin). This product is relatively safe and there are not many side effects, so long as a person carefully monitors his or her diet and has regular blood tests so their doctor can check the…
The makes of Xarelto (Bayer and Johnson & Johnson) took a major hit this week in terms of the future of there flagship drug. Xarelto is a member of a relatively new class of drugs called New Oral Anticoagulants (NOACs). NOACs are used for patients who suffer from a series…
There is no question that Xarelto has been linked to a lot of serious bleeding disorders, many of which resulted in death. There are many reasons the drug has proven so dangerous to users, but a lot of the problems are result of the reportedly negligent manner in which Bayer…
A man from Florida has filed a new Xarelto injury lawsuit against Janssen Pharmaceuticals (a division of Johnson & Johnson, which is the U.S. marketing partner of Xarelto) and Bayer A.G. which is the German pharmaceutical giant that manufactures the medication. As part of this lawsuit, he is claiming negligent…
A recent article from Medpage Today looks at new uses being proposed for a class of medications know as new oral anticoagulants (NOACs). This is a fairly new class of medications that includes Xarelto, Eliquis, Pradaxa, and Savaysa. These medications were designed primary to treat patients who suffer from a…
According to a recent news article from the Louisiana Record, the surviving daughter of a man from Ohio claims that her father died as a result of complications due to taking Xarelto. The complaint was filed on April 8, 2016 in a United States District Court. Plaintiff filed the suit…
Janssen, which is a division of pharmaceutical giant Johnson & Johnson, is the U.S. marketing partner of Bayer, the German drugmaker that manufactures Xarelto, and has released a report that its new oral anticoagulant (NOAC) is superior to Warfarin (Coumadin) in reducing the risk of ischemic stroke, according to a…
A recent feature from CBS News examined whether Johnson & Johnson and Bayer, the makers of Xarelto, knowingly withheld certain important data for a letter to be published in the New England Journal of Medicine. The specific claim made by lawyers for Xarelto plaintiffs in the multi-district litigation (MDL) class action…
According to a recent news feature from the New York Times, the United States Food and Drug Administration (FDA) is now conducting an investigation into whether a blood testing device used during clinical trials, which we now know to be defective, led to an approval of Xarelto that never should…